91 related articles for article (PubMed ID: 1280356)
21. Human papillomavirus detection in paraffin-embedded cervical carcinomas and metastases of the carcinomas by the polymerase chain reaction.
Claas EC; Melchers WJ; van der Linden HC; Lindeman J; Quint WG
Am J Pathol; 1989 Oct; 135(4):703-9. PubMed ID: 2552814
[TBL] [Abstract][Full Text] [Related]
22. [Detection of HPV DNA in the uterine cervical lesions by polymerase chain reaction and in situ hybridization].
Kyo S; Inoue M; Nakazawa A; Ogawa H; Ueda G; Tanizawa O
Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):541-8. PubMed ID: 1647430
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus DNA in invasive cervical carcinomas and its association with patient survival: a nested case-control study.
Franco E; Bergeron J; Villa L; Arella M; Richardson L; Arseneau J; Stanimir G
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):271-5. PubMed ID: 8722218
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical expression of mdm2 and p21WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection.
Troncone G; Martinez JC; Palombini L; De Rosa G; Mugica C; Rodriguez JA; Zeppa P; Di Vizio D; Lucariello A; Piris MA
J Clin Pathol; 1998 Oct; 51(10):754-60. PubMed ID: 10023338
[TBL] [Abstract][Full Text] [Related]
25. The diagnostic utility of human papillomavirus-testing in combination with immunohistochemistry in advanced gynaecologic pelvic tumours: a new diagnostic approach.
Park TW; Zivanovic O; Theuerkauf I; Dürkop B; Hernando JJ; Simon M; Büttner R; Kuhn W
Int J Oncol; 2004 Apr; 24(4):829-36. PubMed ID: 15010819
[TBL] [Abstract][Full Text] [Related]
26. Standardized demonstration of silver-stained nucleolar organizer regions-associated proteins in archival oral squamous cell carcinomas and adjacent non-neoplastic mucosa.
Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
Mod Pathol; 1997 Feb; 10(2):98-104. PubMed ID: 9127314
[TBL] [Abstract][Full Text] [Related]
27. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
28. Invasive cervical cancer in young women. Clinicopathologic correlation and demonstration of human papillomavirus by in situ hybridization.
Thomassen LV; Warshaw J; Lawhead RA; Unger ER
J Reprod Med; 1992 Nov; 37(11):901-6. PubMed ID: 1334150
[TBL] [Abstract][Full Text] [Related]
29. Value of AgNOR counts and morphometric analysis of nuclear parameters in premalignant and malignant lesions of the uterine cervix.
Wierzchniewska A; Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 1998; 49(4):297-301. PubMed ID: 10323085
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of human papillomavirus in the survival of cervical cancer patients: an overview of the evidence.
Franco EL
Cancer Epidemiol Biomarkers Prev; 1992; 1(6):499-504. PubMed ID: 1338870
[TBL] [Abstract][Full Text] [Related]
31. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
[TBL] [Abstract][Full Text] [Related]
32. Correlation of human papillomavirus 16 and 18 with prognostic factors in invasive cervical neoplasias.
Kónya J; Veress G; Hernádi Z; Soós G; Czeglédy J; Gergely L
J Med Virol; 1995 May; 46(1):1-6. PubMed ID: 7622999
[TBL] [Abstract][Full Text] [Related]
33. Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer.
Branca M; Ciotti M; Santini D; Bonito LD; Benedetto A; Giorgi C; Paba P; Favalli C; Costa S; Agarossi A; Alderisio M; Syrjänen K;
Am J Clin Pathol; 2004 Dec; 122(6):902-11. PubMed ID: 15539382
[TBL] [Abstract][Full Text] [Related]
34. Standardized AgNOR analysis of the invasive tumour front in oral squamous cell carcinomas.
Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
J Pathol; 1997 Aug; 182(4):450-6. PubMed ID: 9306967
[TBL] [Abstract][Full Text] [Related]
35. Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.
Cheah PL; Looi LM; Ng MH; Sivanesaratnam V
J Clin Pathol; 2002 Jan; 55(1):22-6. PubMed ID: 11825919
[TBL] [Abstract][Full Text] [Related]
36. Localization of p53 protein and human papillomavirus in anogenital squamous lesions: immunohistochemical and in situ hybridization studies in benign, dysplastic, and malignant epithelia.
Walts AE; Koeffler HP; Said JW
Hum Pathol; 1993 Nov; 24(11):1238-42. PubMed ID: 8244324
[TBL] [Abstract][Full Text] [Related]
37. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA.
Higgins GD; Davy M; Roder D; Uzelin DM; Phillips GE; Burrell CJ
Lancet; 1991 Oct; 338(8772):910-3. PubMed ID: 1681267
[TBL] [Abstract][Full Text] [Related]
38. Detection of human papillomavirus in warty carcinoma of the uterine cervix: comparison of immunohistochemistry, in situ hybridization and in situ polymerase chain reaction methods.
Cho NH; Joo HJ; Ahn HJ; Jung WH; Lee KG
Pathol Res Pract; 1998; 194(10):713-20. PubMed ID: 9820868
[TBL] [Abstract][Full Text] [Related]
39. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions.
Tervahauta AI; Syrjänen SM; Väyrynen M; Saastamoinen J; Syrjänen KJ
Anticancer Res; 1993; 13(4):1107-11. PubMed ID: 8394670
[TBL] [Abstract][Full Text] [Related]
40. HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix.
Torres LM; Cabrera T; Concha A; Oliva MR; Ruiz-Cabello F; Garrido F
Tissue Antigens; 1993 Feb; 41(2):65-71. PubMed ID: 8386400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
